skip navigation
Environmental Factor, December 2014

/
Whole Issue PDF
This issue's PDF is still being created and should be available 3-5 business days after the first of the month. Please check back in a few days.

Seminar tackles inflammatory pathways in obesity-related diseases

By Eddy Ball

Nina Jaitly, M.D.

Nina Jaitly, M.D., a contractor for the NIEHS Scientific Review Branch, gave opening and concluding remarks. She is the contact person for the Inflammation Faculty Seminar Series. (Photo courtesy of Steve McCaw)

Ting and Humble

Following her talk, Ting took questions from the audience and from Humble, right. (Photo courtesy of Steve McCaw)

Eling and Schurman

Eling responded to a question, as Schurman, right, looked on. “NAG-1 appears to be a novel protein with potential therapeutic uses in diseases like obesity,” Eling said. (Photo courtesy of Steve McCaw)

Three NIH-funded experts explored the connections between inflammation and obesity Oct. 29 during an Inflammation Faculty Seminar and Webcast.

Speakers included Jenny Ting, Ph.D., University of North Carolina at Chapel Hill; Stephanie Shore, Ph.D., Harvard School of Public Health, who spoke by remote connection; and NIEHS lead scientist emeritus Thomas Eling, Ph.D. The webcast was organized by NIEHS Inflammation Faculty members including Jerrold Heindel, Ph.D., Mike Humble, Ph.D., Nina Jaitly, M.D., and Srikanth Nadadur, Ph.D., of the Division of Extramural Research and Training; and Shepherd Schurman, M.D., of the Division of Intramural Research.

The talks began with a list of grim statistics about the worldwide spread of obesity, insulin resistance, and diabetes. Ting and Shore made convincing arguments about the adverse effects of obesity-related inflammation on metabolic and respiratory health and response to interventions.

In the final presentation, Eling reported on experiments with transgenic mice that offer the tantalizing possibility of discovering a novel approach to antiaging medicine that might actually live up to the hype. “There is a profound effect on longevity [from overexpressing this gene],” he said.

Dire prospects in an ever-fatter world

With one billion people worldwide overweight and 400 million of them clinically obese, a number expected to increase, the outlook for public health is not good, Ting said as she introduced her subject, “Inflammation and Metabolic Disease.”

In a number of experiments using cell lines and model animals, Ting and colleagues have tested an intriguing hypothesis — that saturated fatty acids in the diet can induce inflammasome activation via the normal fatty acid metabolic pathway. Like a fire burning out of control, inflammation spreads throughout the body, especially through the action of the cytokines interleukin-1 beta (IL-1 beta) and tumor necrosis factor alpha.

“It’s really IL-1 that’s blocking insulin sensitivity,” she said, “[but] both of these cytokines are equally important.”

Obesity-related inflammation in the lung

Ting’s reference to inflammation in the lung as related to a high-fat diet segued nicely into Shore's discussion of the synergy of obesity and ozone as a trigger for asthma and airway hyper-resistance, “Responses to Acute Ozone Exposure Are Augmented in Obese Mice: Role of Innate Immune System.”

Shore opened with the observation that obesity is a risk factor for asthma, and weight loss improves asthma outcomes.

Pointing to the usual suspects, Shore expanded the IL family list to include more members that contribute differently to ozone in obese versus lean mice. She also reported that obesity changes the baseline for how well animals responded to treatment for lowering the levels of ILs and related metabolites. “What we see is a very different effect of interventions on lean and obese mice,” she said.

Shore concluded by underscoring the importance of including obesity as a consideration in respiratory studies.

Mice that age slowly and with grace

When the subject turned to Eling’s lean and mean transgenic mice, the news was almost entirely promising. Eling has spent most of his career studying nonsteroidal anti-inflammatory drug-activated gene (NAG-1), initially for its role in programmed cell death and tumor formation and progression in cancer.

In experiments with transgenic mice overexpressing NAG-1, Eling and colleagues made several important observations about the experimental mice compared to wild-type mice. The transgenic mice had fewer age-associated lesions, less adipose tissue, lower expression of inflammatory cytokines, more efficient energy metabolism, and improved glucose tolerance and utilization. He also reported that caspase-1 activity was lower in lean NAG-1 mice and attenuated in NAG-1 mice on a high fat diet.

Noting this apparent resistance to high-fat diet induced obesity, Eling observed, “The [lean] mice actually eat more, but they’re thinning.”

Underscoring NAG-1 as a novel protein with potential therapeutic uses in disease such as obesity, he concluded, “All these are the characteristics of a mouse that’s going to live longer.… There is a profound effect on longevity.”


Inflammation Faculty seminar series

The Inflammation Faculty is an interdisciplinary, cross-division initiative that brings together scientists from in-house research labs, scientific grants administration, and the National Toxicology Program to advance understanding of inflammation-related disease processes. As one of its activities, the group is sponsoring leading-edge seminars.

Inflammation is one of the areas identified as a priority in the 2012-2017 NIEHS Strategic Plan.

The next seminar in the series will take place Dec. 11 and highlight “Methods at NTP to Identify Biomarkers of Inflammation.”

Individuals interested in the faculty or with needs for accommodation to attend seminars should contact Nina Jaitly, M.D., at (919) 541-7854 or inflammation@niehs.nih.gov.



"GEMS meeting focuses on ..." - previous story Previous story Next story next story - "NIEHS-funded researchers find potential ..."
December 2014 Cover Page

Back to top Back to top